DrugDashboards

Market view

lidocaine hydrochloride and epinephrine

36 marketed package NDCs · 6 active manufacturers

Most dispensed: 10 mg/mL; 10 ug/mL · Injection, Solution · #10 vial, multi-doses/carton / 20 ml in 1 vial, multi-dose

All formsInjection, Solution (35)Solution (1)

The short version

6 companies supply this market — a reasonable cushion if one runs into trouble. The price has held steady around $0.1391 per mL over the past year. It is in shortage right now — FDA lists the reason as “other”.

Price range and competition

RSS: changes for this drug

Every company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.

$0$0.05$0.1$0.15Jul 2014Sep 202606companies actively selling

Latest · Sep 2026 — typical price $0.1391 · middle half $0.1391–$0.1391 · full range $0.1391–$0.1391 · 1 products · 6 companies

middle half of companies’ pricestypical (median) pricecompanies actively selling (bottom lane)Priced per mLⓘSource: CMS NADAC
ⓘ How this was built
Data sources
  • CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
  • CMS Federal Upper Limit files (weighted AMP)
  • FDA NDC Directory (openFDA) — maker roster
Method

Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

What changed in the last 90 days

Every detected change for lidocaine hydrochloride and epinephrine, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in beta-Adrenergic Agonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Lidocaine hydrochloride and epinephrine in shortage right now?
Yes. FDA currently lists Lidocaine hydrochloride and epinephrine in shortage, with the reason given as "other". This page is rebuilt every morning from FDA's shortage database.
Who makes Lidocaine hydrochloride and epinephrine?
6 companies have marketed Lidocaine hydrochloride and epinephrine in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
What does Lidocaine hydrochloride and epinephrine cost?
The typical pharmacy pays about $0.1391 per mL, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

Shortage reports for this molecule

  • In shortage now — Lidocaine Hydrochloride And Epinephrine, Injection, 1 g/50 mL (2%; 1:100,000) (NDC 0409-3182-03)Feb 22, 2012
  • In shortage now — Lidocaine Hydrochloride And Epinephrine, Injection, 2.5 g/50 mL (0.5%; 1:200,000) (NDC 0409-3177-01)Feb 22, 2012
  • In shortage now — Lidocaine Hydrochloride And Epinephrine, Injection, 200 mg/20 mL (1%; 1:100,000) (NDC 0409-3178-01)Feb 22, 2012
  • In shortage now — Lidocaine Hydrochloride And Epinephrine, Injection, 300 mg/30 mL (1%; 1:100,000) (NDC 0409-3178-02)Feb 22, 2012
  • In shortage now — Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:100,000) (NDC 0409-3182-01)Feb 22, 2012
  • In shortage now — Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:200,000) (NDC 0409-3183-01)Feb 22, 2012

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.